Gabrielle B. Fredman, Ph.D.
Affiliations: | 2009 | Boston University, Boston, MA, United States |
Area:
DentistryGoogle:
"Gabrielle Fredman"Parents
Sign in to add mentor| Thomas E. Van Dyke | grad student | 2009 | Boston University | |
| (Resolvin E1 regulation of platelet functions: Novel pathways in resolution.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fredman G, Serhan CN. (2024) Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease. Nature Reviews. Cardiology |
| Fredman G, Khan S. (2023) Specialized pro-resolving mediators enhance the clearance of dead cells. Immunological Reviews. 319: 151-157 |
| Spite M, Fredman G. (2023) Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease. Advances in Pharmacology (San Diego, Calif.). 97: 257-281 |
| Grazda R, Seyfried AN, Maddipatti KR, et al. (2023) Impaired inflammation resolution in murine bone marrow failure is rescued by Resolvin E1 treatment. Biorxiv : the Preprint Server For Biology |
| Fredman G, MacNamara KC. (2022) Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect. Cardiovascular Research. 117: 2563-2574 |
| Decker C, Sadhu S, Fredman G. (2021) Pro-Resolving Ligands Orchestrate Phagocytosis. Frontiers in Immunology. 12: 660865 |
| Gerlach BD, Marinello M, Heinz J, et al. (2019) Resolvin D1 promotes the targeting and clearance of necroptotic cells. Cell Death and Differentiation |
| Fredman G. (2019) Can Inflammation-Resolution Provide Clues to Treat Patients According to Their Plaque Phenotype? Frontiers in Pharmacology. 10: 205 |
| Yurdagul A, Doran AC, Cai B, et al. (2017) Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis. Frontiers in Cardiovascular Medicine. 4: 86 |
| Fredman G, Tabas I. (2017) Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy. The American Journal of Pathology. 187: 1211-1221 |